PV Bulletin

IRIS guide to registration and RPIs

This updated guide details the process for registration and obtaining Research Product Identifiers (RPIs) within the IRIS system.

Primary source: European Medicines Agency

PV Impact Brief

Urgency: HighConfidence: high

What changed

The guide specifies that all submissions related to pharmacovigilance and safety in the EU must utilize the IRIS system for registration, with the requirement to request a new Research Product Identifier (RPI) if not already associated with an existing one.

Why it matters

Accurate registration and management of RPIs are essential for compliance with EU pharmacovigilance regulations, ensuring that organizations can effectively engage in safety monitoring and regulatory submissions.

Action needed

Organizations must establish an active EMA user account, ensure they have a valid EMA customer account number, and complete the SPOR/OMS registration process within five to ten working days if not previously registered.

Relevant for
Regulatory Intelligence LeadSignal Management LeadQPPV
Processes impacted
Country ComplianceSignal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review before 2026-06-15.

Policy change details

Document type
Procedural Guidance
Policy status
revised
Publication date
2026-06-15
Effective date
2026-06-15
Policy change
This updated guide details the process for registration and obtaining Research Product Identifiers (RPIs) within the IRIS system. RPIs are essential for identifying products across various regulatory procedures, including safety monitoring and clinical trial applications.

Key changes

Detailed steps for industry stakeholders to register their organizations and products in the IRIS platform to enable regulatory interactions.

Affected workflows

Country ComplianceSignal Management

Responsible groups

PV OperationsRegulatory Affairs

PV impact

Registration in IRIS is a prerequisite for all pharmacovigilance and safety-related submissions in the EU. Correct RPI management is critical for data integrity across PV databases.

View regulator source

Source document details

Exact policy details

EMA user account requirement
Must have an active EMA user account.
Applies to: All applicants including sponsors of Orphan Designation or acting on their behalf.
Section 1.1.1 · p. 4 · High · Source
Organisation registration in OMS timelines
The SPOR/OMS registration process takes five to ten working days.
Applies to: For organizations not already included in OMS.
Section 1.1.2 · p. 5 · High · Source
EMA customer account number requirement
Applicants must have a valid EMA Customer Account Number.
Applies to: For submissions, including parallel distribution notifications.
Section 1.1.3 · p. 5 · High · Source
Research Product Identifier (RPI)
Each new application must be associated with an existing RPI, or a new RPI must be requested.
Applies to: For scientific procedures in IRIS.
Section 1.1.4 · p. 5 · High · Source

Extracted documents

Evidence and confidence

Confidence: highSource updated: Jun 15, 2026

Full briefing

Practical implication

Organizations must establish an active EMA user account, ensure they have a valid EMA customer account number, and complete the SPOR/OMS registration process within five to ten working days if not previously registered.

Registration in the IRIS system is now a prerequisite for all pharmacovigilance and safety-related submissions in the EU, effective from June 15, 2026. Proper management of RPIs is critical for maintaining data integrity across pharmacovigilance databases.

What changed: The guide specifies that all submissions related to pharmacovigilance and safety in the EU must utilize the IRIS system for registration, with the requirement to request a new Research Product Identifier (RPI) if not already associated with an existing one.

Why it matters: Accurate registration and management of RPIs are essential for compliance with EU pharmacovigilance regulations, ensuring that organizations can effectively engage in safety monitoring and regulatory submissions.

Practical implication: Organizations must establish an active EMA user account, ensure they have a valid EMA customer account number, and complete the SPOR/OMS registration process within five to ten working days if not previously registered.

View original source

Published from the Firecrawl policy change extraction pipeline.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward